Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification
about
Targets, models and challenges in osteoarthritis researchA systems view of risk factors for knee osteoarthritis reveals insights into the pathogenesis of the diseaseGenome-Wide DNA Methylation Study Identifies Significant Epigenomic Changes in Osteoarthritic Subchondral Bone and Similarity to Overlying Cartilage.Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis.Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial.Differentiation between osteoarthritis and psoriatic arthritis: implications for pathogenesis and treatment in the biologic therapy eraAMPA/kainate glutamate receptors contribute to inflammation, degeneration and pain related behaviour in inflammatory stages of arthritis.Immune modulation to improve tissue engineering outcomes for cartilage repair in the osteoarthritic joint.Monoclonal antibodies for the treatment of osteoarthritis.Effects of photobiomodulation therapy, pharmacological therapy, and physical exercise as single and/or combined treatment on the inflammatory response induced by experimental osteoarthritis.Protective effects of tumor necrosis factor-α blockade by adalimumab on articular cartilage and subchondral bone in a rat model of osteoarthritisOsteoRheumatology: a new discipline?New findings in osteoarthritis pathogenesis: therapeutic implications.Suppressive Effects of Insulin on Tumor Necrosis Factor-Dependent Early Osteoarthritic Changes Associated With Obesity and Type 2 Diabetes Mellitus.Osteoarthritis in 2012: Parallel evolution of OA phenotypes and therapies.Biologic agents in osteoarthritis: hopes and disappointments.New and emerging treatments for osteoarthritis management: will the dream come true with personalized medicine?Hand osteoarthritis-nonpharmacological and pharmacological treatments.Emerging drugs for the treatment of knee osteoarthritis.New discovery rarely runs smooth: an update on progranulin/TNFR interactionsInvestigational drugs for the treatment of osteoarthritis.Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment?Hypothesis-free analyses from a large psoriatic arthritis cohort support merger to consolidated peripheral arthritis definition without subtyping.Developing anti-inflammatory therapeutics for patients with osteoarthritis.The role of progranulin in arthritis.MRI findings predict radiographic progression and development of erosions in hand osteoarthritis.In Vivo Articular Cartilage Regeneration Using Human Dental Pulp Stem Cells Cultured in an Alginate Scaffold: A Preliminary Study.Osteoarthritis, a disease bridging development and regeneration.A hospital-based observational cohort study exploring pain and biomarkers in patients with hand osteoarthritis in Norway: The Nor-Hand protocol.Erlotinib and gefitinib, epidermal growth factor receptor kinase inhibitors, may treat non-cancer-related tumor necrosis factor-α mediated inflammatory diseases.Does progranulin account for the opposite effects of etanercept and infliximab/adalimumab in osteoarthritis?: Comment on Olson et al.: "Therapeutic Opportunities to Prevent Post-Traumatic Arthritis: Lessons From the Natural History of Arthritis AfteResponse to 'In erosive hand osteoarthritis more inflammatory signs on ultrasound are found than in the rest of hand osteoarthritis' by Kortekaas et al.[Pharmacological therapy of arthrosis].Autologous Chondrocyte Implantation in Osteoarthritic Surroundings: TNFα and Its Inhibition by Adalimumab in a Knee-Specific Bioreactor.Current status and future prospects for disease modification in osteoarthritis.Brief Report: Association of Inflammation With Development of Erosions in Patients With Hand Osteoarthritis: A Prospective Ultrasonography Study.What is the role of imaging in the clinical diagnosis of osteoarthritis and disease management?Intramuscular clodronate in erosive osteoarthritis of the hand is effective on pain and reduces serum COMP: a randomized pilot trial-The ER.O.D.E. study (ERosive Osteoarthritis and Disodium-clodronate Evaluation).Therapeutics in Osteoarthritis Based on an Understanding of Its Molecular Pathogenesis.A need for new imaging modality to detect inflammation in rheumatoid arthritis and osteoarthritis?
P2860
Q26850147-0EC3C4DE-A728-4288-A085-01A683CBA216Q27008858-5452DC3B-DAAE-452C-A161-2997245A7326Q33833496-01075442-5297-4330-9AA8-11F2F227E44CQ33880198-D8445EEA-8A1B-4426-A202-DBB40B6B5C0EQ34446781-4004E1E4-FB6A-4B5A-9B71-AAA2D0807947Q34727681-3B8549CE-6E62-4332-928B-3CFF945FA1ACQ34818966-A98013B7-7C6C-497E-B52D-FE6F8B4805DFQ35064664-63968EF1-08B3-427F-A407-26162F7BFB0EQ36113839-2CAEB49F-2D3F-4003-8A44-91D329D78C3AQ36160150-B21DA42A-664A-4EB9-B2D9-65B0C50E19B9Q36196730-AE698B03-AA28-4F7C-9358-3BDB1654623AQ36246080-5955BCDF-8CB8-4F4C-80C4-D2C3709D9683Q36515489-8D510175-4DC7-405C-BC04-0BF89C5ABFC9Q36940636-D1D13914-B421-4FA0-83EB-16BC0CB2D2B9Q38072309-98395022-F6DB-4EB7-AEFF-1CD0FB72153BQ38094906-6ADFEEB5-579D-4D79-96B1-056521A008E7Q38138598-AF4B1419-1DFB-40B4-AA85-FFD8E7D5F46AQ38182343-ACA62651-DFC6-4B49-A4D7-1363D9396CBBQ38417521-CE6FE2D6-8036-4EBD-92F6-1177336E6A22Q38593074-251734D5-A279-49DA-A6AB-9664C2C017F2Q38597565-898FDCAD-6514-4F4D-B5CF-7748E0B7917BQ38612010-5A287B1C-9F23-458E-B593-C7A373C49B8FQ38825623-F767018F-2A53-4BF8-9562-F24156181F15Q38833741-209785D0-5B09-4F8A-8AC6-9EBAA630D1ACQ38922852-10570540-6B24-4D39-8ED7-CE7E66B81BC8Q39131957-2E3843FE-D502-4B41-8C30-623F15297893Q41690540-D2FD1505-E5C6-42D5-929D-EA21D0ACC772Q41935934-B7B6750F-6543-4ADD-9338-6AD46F5E9C95Q41977463-64EF90C1-A37A-48D4-822C-0E792B4CB8B3Q42662426-EBEF5D1C-F9BE-4085-A62D-E114571A5540Q42680109-9E813514-B19E-4BD1-85C7-8106D04B82FBQ44506490-A6C7A487-8C45-4971-B8BF-37E744E157BAQ44728458-ABA62DD9-9890-472E-87EC-9066259BEE68Q47445083-6A229F6C-9054-473F-95B2-E9FE182B6E8DQ47570656-76B74D5A-513A-4B11-870A-A6E43C341417Q48941385-7FD9D1EC-7C5E-4308-B8CA-FFB994B3A137Q49915982-AC2DD9E7-41C5-49F2-9A2B-EC07A179716EQ50984708-FF277A4F-1828-40F2-A877-4C8C0EF2E57CQ52679053-0EE44600-D359-4D20-B4DD-358B3CF11091Q53233928-AE7E4C9D-4A75-4706-AACE-833C6B56F5EB
P2860
Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Tumour necrosis factor blockad ...... rial on structure modification
@ast
Tumour necrosis factor blockad ...... rial on structure modification
@en
type
label
Tumour necrosis factor blockad ...... rial on structure modification
@ast
Tumour necrosis factor blockad ...... rial on structure modification
@en
prefLabel
Tumour necrosis factor blockad ...... rial on structure modification
@ast
Tumour necrosis factor blockad ...... rial on structure modification
@en
P2093
P2860
P356
P1476
Tumour necrosis factor blockad ...... rial on structure modification
@en
P2093
Bert Vander Cruyssen
Dirk Elewaut
Ruth Wittoek
P2860
P304
P356
10.1136/ARD.2011.149849
P407
P577
2011-11-29T00:00:00Z